RB1 and adenocarcinoma: Finally, given the importance of RB1 in restraining proliferation, it is also possible that RB1 loss in a subset of tumor cells that had already undergone NEPC lineage plasticity from an adenocarcinoma phenotype may provide a proliferative advantage, accelerating the shift in the tumor population to an NEPC phenotype.